A unique xanthine derivative KMCP-98 with activation of adenosine receptor subtypes

Kuo-Pyng Shen , Rong-Jyh Lin , Chiu-Yin Lin , Lien-Chai Chiang , Wen-Ter Lai , Chang-Jenq Cheng , Ing-Jun Chen , Bin-Nan Wu
{"title":"A unique xanthine derivative KMCP-98 with activation of adenosine receptor subtypes","authors":"Kuo-Pyng Shen ,&nbsp;Rong-Jyh Lin ,&nbsp;Chiu-Yin Lin ,&nbsp;Lien-Chai Chiang ,&nbsp;Wen-Ter Lai ,&nbsp;Chang-Jenq Cheng ,&nbsp;Ing-Jun Chen ,&nbsp;Bin-Nan Wu","doi":"10.1016/S0306-3623(01)00090-8","DOIUrl":null,"url":null,"abstract":"<div><p>KMCP-98 is a newly synthesized adenosine receptor agonist by alkylation at the 7-position of the xanthines nucleus. We first investigated the pharmacological activities of KMCP-98 under in vivo and in vitro conditions. Acute intravenous injection of KMCP-98 (1.0, 2.0 and 3.0 mg/kg) produced a temporary fall in blood pressure and heart rate, followed by a sustained fall in heart rate in pentobarbital-anesthetized Wistar rats. The hypotensive and bradycardiac responses were inhibited by pretreatment with an A<sub>1</sub> adenosine receptor antagonist 8-phenyltheophylline (8-PT, 0.5 mg/kg). Both KMCP-98 and adenosine (0.3–100 μM) produced negative inotropic activitity in isolated guinea pig left atria. The negative inotropic activity of KMCP-98 was significantly blocked by pretreatment with A<sub>1</sub> receptor antagonists 8-PT (10 μM) and xanthine amine congener (XAC, 10 μM), a nonselective adenosine antagonist theophylline (10 μM), a K<sup>+</sup> channel blocker tetraethylammonium (TEA, 10 mM) and a K<sub>ATP</sub> channel blocker glibenclamide (1 μM). KMCP-98 (0.03–30 μM) produced concentration-dependent relaxations in carbachol (1 μM) precontracted guinea pig tracheal smooth muscle. The trachea relaxant response of KMCP-98 was markedly inhibited by A<sub>2</sub>, A<sub>2a</sub> and A<sub>2b</sub> adenosine receptor antagonists 3,7-dimethyl-1-propargylxanthine (DMPX, 10 μM), 8-(3-chlorostyryl)caffeine (CSC, 10 μM) and alloxazine (10 μM), respectively, the nitric oxide synthase (NOS) inhibitor <span>l</span>-NAME (100 μM) and also by TEA and glibenclamide. In addition, KMCP-98 (0.03–30 μM) elicited relaxant response in norepinephrine (3 μM) precontracted rat thoracic aorta in a concentration-dependent manner. The thoracic aorta relaxant response of KMCP-98 was also significantly inhibited by DMPX, CSC, alloxazine, <span>l</span>-NAME, TEA and glibenclamide. Furthermore, the binding characteristics of KMCP-98, adenosine and 5′-<em>N</em>-ethylcarboxaminoadenosine (NECA) were evaluated in [<sup>3</sup>H]DPCPX and [<sup>3</sup>H]CGS 21680 binding to rat cortex and striatum, respectively. The <em>K</em><sub>i</sub> values of KMCP-98 for predominate A<sub>1</sub> and A<sub>2</sub> adenosine receptor sites were 3908±952 and 158±10 nM, respectively. In conclusion, KMCP-98 was found to be a xanthine-based adenosine receptor agonist associated cardiac depression, tracheal and aortic smooth muscle relaxations.</p></div>","PeriodicalId":12607,"journal":{"name":"General Pharmacology-the Vascular System","volume":"35 1","pages":"Pages 47-57"},"PeriodicalIF":0.0000,"publicationDate":"2000-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0306-3623(01)00090-8","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"General Pharmacology-the Vascular System","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0306362301000908","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

KMCP-98 is a newly synthesized adenosine receptor agonist by alkylation at the 7-position of the xanthines nucleus. We first investigated the pharmacological activities of KMCP-98 under in vivo and in vitro conditions. Acute intravenous injection of KMCP-98 (1.0, 2.0 and 3.0 mg/kg) produced a temporary fall in blood pressure and heart rate, followed by a sustained fall in heart rate in pentobarbital-anesthetized Wistar rats. The hypotensive and bradycardiac responses were inhibited by pretreatment with an A1 adenosine receptor antagonist 8-phenyltheophylline (8-PT, 0.5 mg/kg). Both KMCP-98 and adenosine (0.3–100 μM) produced negative inotropic activitity in isolated guinea pig left atria. The negative inotropic activity of KMCP-98 was significantly blocked by pretreatment with A1 receptor antagonists 8-PT (10 μM) and xanthine amine congener (XAC, 10 μM), a nonselective adenosine antagonist theophylline (10 μM), a K+ channel blocker tetraethylammonium (TEA, 10 mM) and a KATP channel blocker glibenclamide (1 μM). KMCP-98 (0.03–30 μM) produced concentration-dependent relaxations in carbachol (1 μM) precontracted guinea pig tracheal smooth muscle. The trachea relaxant response of KMCP-98 was markedly inhibited by A2, A2a and A2b adenosine receptor antagonists 3,7-dimethyl-1-propargylxanthine (DMPX, 10 μM), 8-(3-chlorostyryl)caffeine (CSC, 10 μM) and alloxazine (10 μM), respectively, the nitric oxide synthase (NOS) inhibitor l-NAME (100 μM) and also by TEA and glibenclamide. In addition, KMCP-98 (0.03–30 μM) elicited relaxant response in norepinephrine (3 μM) precontracted rat thoracic aorta in a concentration-dependent manner. The thoracic aorta relaxant response of KMCP-98 was also significantly inhibited by DMPX, CSC, alloxazine, l-NAME, TEA and glibenclamide. Furthermore, the binding characteristics of KMCP-98, adenosine and 5′-N-ethylcarboxaminoadenosine (NECA) were evaluated in [3H]DPCPX and [3H]CGS 21680 binding to rat cortex and striatum, respectively. The Ki values of KMCP-98 for predominate A1 and A2 adenosine receptor sites were 3908±952 and 158±10 nM, respectively. In conclusion, KMCP-98 was found to be a xanthine-based adenosine receptor agonist associated cardiac depression, tracheal and aortic smooth muscle relaxations.

一种独特的黄嘌呤衍生物KMCP-98,具有腺苷受体亚型的激活
KMCP-98是在黄嘌呤核7位烷基化合成的腺苷受体激动剂。我们首先在体内和体外条件下研究了KMCP-98的药理活性。急性静脉注射KMCP-98(1.0、2.0和3.0 mg/kg)可使戊巴比妥麻醉的Wistar大鼠血压和心率暂时下降,随后心率持续下降。A1腺苷受体拮抗剂8-苯基茶碱(8-PT, 0.5 mg/kg)预处理可抑制降压和心动过缓反应。KMCP-98和腺苷(0.3 ~ 100 μM)在离体豚鼠左心房均呈负性肌力活性。A1受体拮抗剂8-PT (10 μM)、黄嘌呤胺同属物(XAC, 10 μM)、非选择性腺苷拮抗剂茶碱(10 μM)、K+通道阻滞剂四乙基铵(TEA, 10 mM)和KATP通道阻滞剂格列本脲(1 μM)预处理可显著阻断KMCP-98的负性肌力活性。KMCP-98 (0.03 ~ 30 μM)对豚鼠气管平滑肌(1 μM)产生浓度依赖性松弛。A2、A2a和A2b腺苷受体拮抗剂3,7-二甲基-1-丙基黄嘌呤(DMPX, 10 μM)、8-(3-氯苯乙烯基)咖啡因(CSC, 10 μM)和alloxazine (10 μM)、一氧化氮合酶(NOS)抑制剂l-NAME (100 μM)以及TEA和格列本脲均能显著抑制KMCP-98的气管松弛反应。此外,KMCP-98 (0.03 ~ 30 μM)在去甲肾上腺素(3 μM)预收缩大鼠胸主动脉中诱导松弛反应呈浓度依赖性。DMPX、CSC、alloxazine、l-NAME、TEA和格列本脲均能显著抑制KMCP-98的胸主动脉舒张反应。在[3H]DPCPX和[3H]CGS 21680中,分别评价KMCP-98、腺苷和5′- n -乙基羧胺腺苷(NECA)与大鼠皮层和纹状体的结合特性。KMCP-98在主要A1和A2腺苷受体位点的Ki值分别为3908±952和158±10 nM。综上所述,KMCP-98是一种以黄嘌呤为基础的腺苷受体激动剂,与心脏抑制、气管和主动脉平滑肌松弛有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信